why choose us

First received: June 28, 2023

Clinical Trial: A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Major Depressive Disorder

Study Type: OBSERVATIONAL


Official Title: Post-marketing Database Survey: A Cohort Study of Comparison the Risk of Haemorrhage (Serious Intracranial Haemorrhage Such as Cerebral Haemorrhage and Subarachnoid Haemorrhage) Between Vortioxetine T

Brief Summary: This study is a retrospective database study in Japan to evaluate the relative risk of serious intracranial hemorrhage requiring hospitalization between Vortioxetine tablet treatment and selective serotonin reuptake inhibitor (SSRI) treatment for patients with depression.This survey will conduct in use of medical database called JMDC claims database.

Read more